Agree. Skated through another ASM with zero commitment to schedule, goals or $ expectations.
No analysts with any credentials because she offers no commitment of outlook. After May 10 it should be obvious to most she does not belong there. The BOD are no winners. Who of the group has experience bringing any immunotherapy or any drug to market?